Results 181 to 190 of about 79,696 (205)
Some of the next articles are maybe not open access.
Phosphodiesterase 5 inhibitors and adrenal incidentalomas
Medical Hypotheses, 2019Ioannis, Ilias, Lina, Zabuliene
openaire +2 more sources
In Defense of Phosphodiesterase 5 Inhibitors—Reply
JAMA Ophthalmology, 2022Mohit, Sodhi +2 more
openaire +2 more sources
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap, Johann Sebastian de Bono
exaly
Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer
Ca-A Cancer Journal for Clinicians, 2005Ruth M O'regan
exaly
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
New England Journal of Medicine, 2009Stephen L Archer
exaly
Phosphodiesterase-5 Inhibitors in Cardioprotection
2013Mahesh Thirunavukkarasu +1 more
openaire +1 more source
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Ca-A Cancer Journal for Clinicians, 2010Kristina M Cook, William D Figg
exaly